All Articles

As AI adoption outpaces governance, a new firm is creating a credit score-like system for AI risk. With a high-powered advisory board, is this the key to resilience?

MacPaw's Moonlock didn't just win; it swept the Stevie Awards. This triple victory for its team, talent, and tech reveals a deeper strategy for Mac users.

With the launch of its TED drug Lumvoa, Viridian Therapeutics steps into the commercial ring. But can early momentum and a deep pipeline justify the cost?

A "Product of the Year" award for a dog treat is more than just news. It reveals a deep shift in corporate strategy and the growing pet wellness system.

A strategic hire at RegTech firm RiskExec reveals a new reality: AI is no longer just a tool, but a core strategy for navigating financial regulation.

GPGI's Q2 results show a tale of two subsidiaries. While fintech darling CompoSecure hits records, industrial giant Husky faces market drag. Can one system steer both?

With a 32% jump in royalty revenue and a game-changing acquisition, Ligand Pharmaceuticals solidifies its market dominance. But is the growth sustainable?

The Edinburgh International Festival bets big on America's 250th, leveraging cultural diplomacy and star power for a major economic and reputational payoff.

A new government initiative is accelerating a massive Québec phosphate mine, revealing a strategy to secure vital resources for food and batteries.

A new federal grant is helping Frontier Lithium turn mining by-products into valuable fertilizer, a key step in building a greener North American battery supply chain.

A controversial drug program is the unlikely financial engine keeping rural hospitals afloat. Inside Phoebe Putney's model for reinvesting savings.

With a return to profitability and digital revenue soaring, Lee Enterprises' Q3 results reveal a potent mix of financial strategy and digital transformation.

Gogo's Q2 results show a net loss, but a 40% surge in military revenue is funding its critical, costly transition to next-gen Galileo and 5G services.

With nearly $800M in cash, Immunovant is all-in on a single drug, IMVT-1402. Can its ambitious six-front clinical strategy justify the burn and win the race?

The Yankees partner with prediction market Polymarket, signaling a major shift in sports sponsorship, fan engagement, and regulated financial technology.

American Growth Insurance's acquisition of Heller-Kowitz isn't just another deal. It’s the first move in a high-stakes bet to rebuild Main Street agencies.

Fox Corp. posts record earnings fueled by the World Cup, but the real story is its massive $22B bet on Roku to conquer the future of television streaming.

With its acquisition of Global Ledger and the hire of Novo's co-founder, OpenFX is building a bank for the fintechs that traditional finance won't touch.

A shocking $31M loss forces ethical egg purveyor Vital Farms into a defensive crouch, testing if brand loyalty can survive a brutal market oversupply.

The utility's strong Q2 results are fueled by massive energy demand from new data centers, prompting a $1B capital plan increase and promising regional growth.